First Trust Indxx MeddevMDEVETF
13F holders, Q4 2024 (December 31)7holders
0new positions
0sold out
$20.56avg. 13F price*
At the end of Q4 2024, 7 institutions reported holding First Trust Indxx Meddev (MDEV) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holders were Glenview Trust Co ($758K), Arax Advisory Partners ($619K) and Jane Street Group, LLC ($487K).
- Company
- First Trust Indxx Meddev
- CUSIP
- 33738R639
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 4,123 shares bought and 126 shares sold, net +3,997 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Glenview Trust Co | 0.01% | No change | 36,870 | $758K |
| Arax Advisory Partners | 0.04% | Add +7.7% | 30,103 | $619K |
| Jane Street Group, LLC | 0.00% | Add +6.9% | 23,707 | $487K |
| Susquehanna International Group, LLP | 0.00% | Add +4.3% | 11,086 | $228K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,405 | $29K |
| Harbour Investments, Inc. | 0.00% | No change | 1,302 | $27K |
| UBS Group AG | 0.00% | Reduce -16.0% | 660 | $14K |
"% of holder's portfolio" is MDEV's weight in each manager's 13F, not the share of First Trust Indxx Meddev the manager owns.